Drug Delivery

Feb 29, 2016
A reformulated version of Rose Bengal, PV-10, may be used to treat melanoma when injected directly into tumors.
Feb 04, 2016
By BioPharm International Editors
ViaCyte enters Phase I/Phase II clinical trials for VC-01, a candidate treatment for the treatment of type 1 diabetes.
Dec 11, 2015
By BioPharm International Editors
Researchers from Oregon State University develop a new three-drug delivery system for cancer treatment.
Dec 09, 2015
By BioPharm International Editors
Assembly Biosciences reported a successful clinical study validating the use of the Gemicel technology platform for the oral delivery of biologic medications.
Dec 04, 2015
The company plans to reformulate injectable products to make them into inhaled and intranasal medications.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 13, 2015
BioPharm International
By BioPharm International Editors
A new consortium involving Arecor, Fujifilm Diosynth Biotechnologies, and the UK's Center for Process Innovation will focus on formulation innovation as a way to improve downstream processing and reduce biopharmaceutical cost.
Oct 14, 2015
By BioPharm International Editors
The company presented a portfolio of new products during the meeting in Madrid.
Oct 02, 2015
BioPharm International
This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.
native1_300x100
lorem ipsum